These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 9579847)
1. Predicting chemotherapeutic response to small-cell lung cancer of platinum compounds by thallium-201 single-photon emission computerized tomography. Tokuchi Y; Isobe H; Takekawa H; Hanada T; Ishida T; Ogura S; Itoh K; Furudate M; Saito K; Kawakami Y Br J Cancer; 1998 Apr; 77(8):1363-8. PubMed ID: 9579847 [TBL] [Abstract][Full Text] [Related]
2. 201Tl SPECT as an indicator for early prediction of therapeutic effects in patients with non-small cell lung cancer. Suga K; Kume N; Nishigauchi K; Ogasawara N; Hara A; Miura G; Matsumoto T; Matsunaga N Ann Nucl Med; 1998 Dec; 12(6):355-62. PubMed ID: 9972373 [TBL] [Abstract][Full Text] [Related]
3. Thallium-201 SPECT in advanced non-small cell lung cancer: in relation with chemotherapeutic response, survival, distant metastasis and p53 status. Cermik TF; Yüksel M; Karlikaya C; Doğanay L; Türe M; Berkarda S Ann Nucl Med; 2003 Jul; 17(5):369-74. PubMed ID: 12971634 [TBL] [Abstract][Full Text] [Related]
4. Relationship between cancer cell proliferation and thallium-201 uptake in lung cancer. Ishibashi M; Fujii T; Yamana H; Fujimoto K; Rikimaru T; Hayashi A; Kurata S; Hayabuchi N Ann Nucl Med; 2000 Aug; 14(4):255-61. PubMed ID: 11023025 [TBL] [Abstract][Full Text] [Related]
5. Retention index of thallium-201 single photon emission computerised tomography (SPECT) as an indicator of metastasis in adenocarcinoma of the lung. Takekawa H; Itoh K; Abe S; Ogura S; Isobe H; Sukou N; Furudate M; Kawakami Y Br J Cancer; 1994 Aug; 70(2):315-8. PubMed ID: 8054281 [TBL] [Abstract][Full Text] [Related]
6. Comparative study of Tc-99m MIBI and TI-201 SPECT in predicting chemotherapeutic response in non-small-cell lung cancer. Nishiyama Y; Yamamoto Y; Satoh K; Ohkawa M; Kameyama K; Hayashi E; Fujita J; Tanabe M Clin Nucl Med; 2000 May; 25(5):364-9. PubMed ID: 10795697 [TBL] [Abstract][Full Text] [Related]
7. Thallium-201 uptake, histopathological differentiation and Na-K ATPase in lung adenocarcinoma. Takekawa H; Itoh K; Abe S; Ogura S; Isobe H; Furudate M; Kawakami Y J Nucl Med; 1996 Jun; 37(6):955-8. PubMed ID: 8683319 [TBL] [Abstract][Full Text] [Related]
8. Relationship between cancer cell proliferation, tumour angiogenesis and 201Tl uptake in non-small cell lung cancer. Fujita S; Nagamachi S; Nishii R; Wakamatsu H; Futami S; Tamura S; Matsuzaki Y; Onizuka T; Hatakeyama K; Asada Y Nucl Med Commun; 2006 Dec; 27(12):989-97. PubMed ID: 17088685 [TBL] [Abstract][Full Text] [Related]
9. Comparative study of technetium-99m-sestamibi and thallium-201 SPECT in predicting chemotherapeutic response in small cell lung cancer. Yamamoto Y; Nishiyama Y; Satoh K; Takashima H; Ohkawa M; Fujita J; Kishi T; Matsuno S; Tanabe M J Nucl Med; 1998 Sep; 39(9):1626-9. PubMed ID: 9744357 [TBL] [Abstract][Full Text] [Related]
10. Usefulness of triple-phase thallium-201 SPECT in non-small-cell lung cancer (NSCLC): association with proliferative activity. Fujita S; Nagamachi S; Wakamatsu H; Nishii R; Futami S; Tamura S; Matsuzaki Y; Onizuka T; Hatakeyama K; Asada Y Ann Nucl Med; 2008 Dec; 22(10):833-9. PubMed ID: 19142701 [TBL] [Abstract][Full Text] [Related]
11. Scintigraphic prediction of resistance to radiation and chemotherapy in patients with lung carcinoma: technetium 99m-tetrofosmin and thallium-201 dual single photon emission computed tomography study. Fukumoto M; Yoshida D; Hayase N; Kurohara A; Akagi N; Yoshida S Cancer; 1999 Oct; 86(8):1470-9. PubMed ID: 10526275 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of radiotherapeutic response in non-small cell lung cancer patients by technetium-99m MIBT and thallium-201 chloride SPET. Nishiyama Y; Yamamoto Y; Fukunaga K; Kiuchi T; Satoh K; Takashima H; Ohkawa M; Tanabe M Eur J Nucl Med; 2000 May; 27(5):536-41. PubMed ID: 10853809 [TBL] [Abstract][Full Text] [Related]
13. Is ¹⁸F-fluorodeoxyglucose positron emission tomography-based metabolic response superior to Response Evaluation Criteria In Solid Tumors-based response after two cycles of platinum-based chemotherapy in predicting clinical outcome of untreated patients with advanced non-small cell lung cancer? Yang JJ; Wang SX; Zhong WZ; Xu CR; Yan HH; Wu YL Nucl Med Commun; 2011 Dec; 32(12):1113-20. PubMed ID: 21934546 [TBL] [Abstract][Full Text] [Related]
14. [Comparative evaluation of 99mTc-MIBI (hexakis2-methoxy isobutyl isonitrile) and 201Tl-chloride in primary lung cancer]. Yamamoto Y; Kawasaki Y; Nishiyama Y; Fukunaga K; Satoh K; Takashima H; Ohkawa M; Kumazawa Y; Fujita J; Tanabe M Kaku Igaku; 1996 May; 33(5):501-11. PubMed ID: 8699618 [TBL] [Abstract][Full Text] [Related]
15. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results. Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671 [TBL] [Abstract][Full Text] [Related]
16. Technetium-99m-MIBI and thallium-201 scintigraphy of primary lung cancer. Nishiyama Y; Kawasaki Y; Yamamoto Y; Fukunaga K; Satoh K; Takashima H; Ohkawa M; Tanabe M J Nucl Med; 1997 Sep; 38(9):1358-61. PubMed ID: 9293787 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of suspected malignant pulmonary lesions with 201Tl single photon emission computed tomography. Tonami N; Yokoyama K; Shuke N; Taki J; Kinuya S; Miyauchi T; Michigishi T; Aburano T; Hisada K; Watanabe Y Nucl Med Commun; 1993 Jul; 14(7):602-10. PubMed ID: 8395035 [TBL] [Abstract][Full Text] [Related]
18. [Usefulness of 201Tl SPECT in the evaluation of treatment effect for primary lung cancer]. Yamaji S Kaku Igaku; 1995 Dec; 32(12):1333-40. PubMed ID: 8587215 [TBL] [Abstract][Full Text] [Related]
19. Platinum compounds in the treatment of advanced breast cancer. Martín M Clin Breast Cancer; 2001 Oct; 2(3):190-208; discussion 209. PubMed ID: 11899413 [TBL] [Abstract][Full Text] [Related]
20. Scintigraphic prediction of response to chemotherapy in patients with breast cancer: Technetium 99m-tetrofosmin and thallium-201 dual single photon emission computed tomography. Takeuchi N; Fukumoto M; Nishioka A; Akagi N; Murata Y; Takeuchi S; Ogawa Y; Yoshida S Int J Oncol; 2002 Jan; 20(1):53-8. PubMed ID: 11743642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]